Treatment of osteoporosis with Denosumab associated with lower risk of incident diabetes especially among elderly: JAMA
Denosumab treatment is associated with a lower risk of incident diabetes especially among elderly patients with osteoporosis, suggests a new study published in the JAMA Network Open. Denosumab, a humanized monoclonal antibody against receptor activator of …